Athyrium Capital Management, LP

All Holdings — 2024 Q3

Portfolio Concentration Analytics: 7.6
Risk-based ENB:
Total Positions
3
Quarter
2024 Q3
Top Holding
N/A (63.1%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-3 of 3
Stock History Sector / Type Port % Prev % Rank / Prev Conviction Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
N/A
Biora Therapeut...
Unknown 63.12% 21.51% #1 1
Prev: #2
10.0 no change no change
P
S
10,929,762 $5,482,368,000 13F Filing 2024-09-30 2024-11-14 (Est.)
PBYI
PUMA BIOTECHNOL...
Healthcare 36.88% 12.21% #2 1
Prev: #3
10.0 no change no change
P
S
1,256,411 $3,203,848,000 2022 Q1 13F Filing 2024-09-30 2024-11-14 (Est.)
N/A
COHERUS BIOSCIE...
Bond/Debt 0.00% 66.28%
Sold All 😨
(Was: #1)
0.3 -30,000,000 -100.0%
CLOSED
$— 13F Filing 2024-09-30 2024-11-14 (Est.)
Showing 1-3 of 3 holdings

Unlock Full Athyrium Capital Management, LP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics